SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Raptech who wrote (1734)11/30/1998 8:02:00 PM
From: Walter Morton  Read Replies (2) of 2742
 
So, you don't want ENDG nor BIOI to merge or buy CIST because of the one for 11 stock exchange? Did you consider CIST's book value? That may get us one share for six shares of CIST.

These companies have had sales in the millions -- $9 million and $20 million respectively. They seem to know how to market their products... something CIST admits to not trying to do:

Message 6536360

LOOK AT THESE COMPANIES:

quicken.com

quicken.com

endogen.com

biosource.com

I don't expect that we would lose much of the value of our stock. We would just have fewer shares.

So, I think it comes down to this: Would you buy ENDG or BIOI if they had a million dollars guaranteed to come in (from an Immunex settlement) and a potential $30+ Million deal with the largest vaccine company in the world?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext